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Conclusions: Compared to CR, VMAT greatly improves conformity and 
reduces mean dose and dose delivered from 20 Gy and higher to the 
lungs and the body.These results led us to plan a new dosimetric 
comparison between VMAT and Helical Tomotherapy. This will be the 
subject of a forthcoming study. 
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Purpose/Objective: To evaluate feasibility, early results and toxicity 
profile of post-operative whole breast irradiation after conserving 
surgery for early breast cancer (EBC) delivered with TomoDirect (TD), 
static angles Tomotherapy, within an accelerated hypofractionated 
(HF) schedule employing a simultaneous integrated boost (SIB) to the 
surgical bed. We herein present early results of a prospective phase II 
trial, undergoing at Ospedale Regionale ‘U. Parini’, AUSL valle 
d’Aosta, Aosta (Italy)  
Materials and Methods: Between June 2011 and June 2012 a total of 
52 consecutive EBC patients have been treated with HF TD at our 
Department. Histologically proven left- and right-sided breast 
adenocarcinoma, pathologically staged pTis/pT1/pT2, pN0-N1 after 
lumpectomy/quadrantectomy, were included (eventual association 
with hormonal therapy, chemotherapy and trastuzumab) . Patients 
were prescribed 45 Gy/20 fractions to the whole breast with a 
concomitant delivery of a SIB dose to the lumpectomy cavity of 0.25 
Gy daily up to 5 adjunctive Gy (total nominal dose of 50 Gy/20 fr 2.5 
Gy daily), employing the TD system. The 95% percentage PTV volume 
should be covered at least by 95% of the prescribed dose. The PTV was 
restricted to <53.5 Gy at 3% volume. Considered organs at risk for 
dosimetric constraints were lungs, heart and contralateral breast. TD 
beam arrangement consisted of 4 to 6 fields according to patients 
characteristics and consequent dose distribution. Acute toxicity was 
scored according to RTOG scale, chronic toxicity according to LENT-
SOMA scale, cosmesis was evaluated according to Harvard criteria and 
quality of life employing EORTC QLQ-C30 and QLQ-BR23 
questionnaires. 
Results: All patients completed the planned radiotherapy program 
with no clinical-related treatment interruptions. Radiation therapy 
was generally well tolerated; 42 patients (81%) had G0-G1 skin 
toxicity, while 10 patients experienced RTOG G2 erythema (19%); no 
grade 3 toxicities were reported. Up to 30 patients achieved a 
minimal follow-up time of 6 months; among them mild skin late 
effects were observed (mainly hyperpigmentation; 4% LENT-SOMA G1). 
Skin cosmesis was judged optimal/good in almost all of these patients 
(98%). Quality of life was generally good (both globally with QLQC-30 
and specifically with QLQ-BR23).As expected no local or systemic 
relapse were detected. 
Conclusions: TD has demonstrated to be a feasible and efficient mean 
to deliver accelerated hypofractionated adjuvant radiation in EBC 
patients after conserving surgery, with an optimal dose distribution, 
negligible toxicity and encouraging clinical results. This technical 
solution is a valid IMRT option for breast radiation treatment. 
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Purpose/Objective: The proximal carotid artery is often included 
within a supraclavicular RT field in patients with node-positive 
disease. It is rational that these patients have a greater risk of 
cerebrovascular events, which has been shown after head and neck 
irradiation. The purpose of our study was to determine the radiation 
doses to carotid artery among three dimensional conformal 
radiotherapy (3DCRT) and intensity modulated radiotherapy (IMRT) 
and to perform carotid sparing intensity modulated radiotherapy (CS-
IMRT) without compromising target volume coverage. 
Materials and Methods: Ten patients who were treated with 
comprehensive 3DCRT were selected. DICOM data were used to create 
virtual IMRT and CS-IMRT plans. The carotid artery was retrospectively 
contoured. The inverse planning for IMRT was constituted and 5-field 
beam arrangement was used. The optimization objectives of the CTV, 
PTV and organ at risks were defined as used for 3DCRT. The dose 
constraints for organ at risk were as follows: V20<20% for ipsilateral 
lung; V30<10% for heart;V10 for contralateral lung; V10 for 
contralateral breast; 50 Gy for ipsilateral brachial plexus. For CS-
IMRT, V35 for ipsilateral carotid artery was additionally defined. The 
prescription dose was 50 Gy at 2 Gy per fraction for three planning. 
≥95% of the PTV received 100% of the prescription dose. The 
parameters used for comparison of planning were V20 for ipsilateral 
lung; V30 for heart, V10 for contralateral lung; V10 for contralateral 
breast,mean, and median maximum dose along with V35 and V50 for 
carotid artery. 
Results: There was a difference in terms of HI and CI among the three 
treatment plans. After pairwise comparison; 3DCRT plans had greater 
HI and had less CI than IMRT and CS-IMRT planings.3DCRT plans had 
significantly higher percentages of V20 ipsilateral lung volume and had 
significantly lower percentages of V10 contralateral lung volume 
compared to IMRT and CS-IMRT planings. Although no difference for 
V20 ipsilateral lung was observed between IMRT plans, the percentage 
of V10 contralateral lung was lower in the CS-IMRT plans compared to 
IMRT plans.  Carotid artery doses were significantly increased with 
IMRT compared to 3DCRT plans. With 3DCRT planning, V35 and V50 
were 57.5% and 12.65%. With IMRT planning, V35 and V50 were 
increased to 63.5%and 44% (p<0.005). After application of dose 
constraints to the carotid arteries, these parameters were found as 
61% and 0% in CS-IMRT planning without compromising target volume 
coverage. The results of dose parameters for planning were 
summarized in Table 1. 
 
 
